Electronic Shoe Insole Monitors Diabetic Foot Health
|
By HospiMedica International staff writers Posted on 14 Oct 2019 |

Image: A graphene insole and smartphone can prevent DFU’s (Photo courtesy of Bonbouton).
A graphene-based insole embedded with a multitude of sensors measures and detects inflammation that could lead to debilitating diabetic foot ulcers (DFUs).
The Bonbouton (New York, NY, USA) Smart Insole, developed in conjunction with the Stevens Institute of Technology (Hoboken, NJ, USA), is designed for insertion into a sneaker or dress shoe to passively monitor feet health in people living with diabetes. The proprietary sensors are made of graphene, an extremely thin sheet of pure carbon with a high flexibility, extreme strength, and electrical and thermal conductivity. The monitoring data are sent to a companion smartphone app, which sends out automatic alerts if an ulcer is starting to form.
The data can also be accessed by the patient and shared with family members, a healthcare provider, or others in order to determine if a surgical intervention or other treatment is needed. Features include compatibility with most footwear styles; four different sizes that can also be trimmed to achieve perfect fit, maximum comfort and effectiveness; easy installation; up to four months of continuous temperature and pressure foot monitoring with the included batteries; and a companion app that is free, easy to set up, and simple to use.
“Bonbouton's smart insoles sense the skin's temperature, pressure, and other foot health-related data, which can alert a patient and his or her healthcare provider when an infection is about to take hold,” said Linh Le, PhD, founder and CEO of Bonbouton. “This simplifies patient self-monitoring and reduces the frequency of doctor visits, which can ultimately lead to a higher quality of life. I am excited to realize the full potential of Bonbouton, taking a technology that I developed as a graduate student at Stevens and growing it into a product that will bring seamless preventative care to patients and save billions of dollars in healthcare costs.”
Graphene is a monolayer atomic-scale honeycomb lattice of carbon atoms which combines the greatest mechanical strength ever measured in any material (natural or artificial) with very lightweight and high elasticity. Graphene has unique optical and thermal properties which allow it to release energy in the form of heat in response to light input; it also has very high electrical conductivity. The high surface area allows bioconjugation with common biomolecules. Andre Geim and Kostya Novoselov of the University of Manchester (United Kingdom) were awarded the Nobel Prize in Physics in 2010 for its development.
Related Links:
Bonbouton
Stevens Institute of Technology
The Bonbouton (New York, NY, USA) Smart Insole, developed in conjunction with the Stevens Institute of Technology (Hoboken, NJ, USA), is designed for insertion into a sneaker or dress shoe to passively monitor feet health in people living with diabetes. The proprietary sensors are made of graphene, an extremely thin sheet of pure carbon with a high flexibility, extreme strength, and electrical and thermal conductivity. The monitoring data are sent to a companion smartphone app, which sends out automatic alerts if an ulcer is starting to form.
The data can also be accessed by the patient and shared with family members, a healthcare provider, or others in order to determine if a surgical intervention or other treatment is needed. Features include compatibility with most footwear styles; four different sizes that can also be trimmed to achieve perfect fit, maximum comfort and effectiveness; easy installation; up to four months of continuous temperature and pressure foot monitoring with the included batteries; and a companion app that is free, easy to set up, and simple to use.
“Bonbouton's smart insoles sense the skin's temperature, pressure, and other foot health-related data, which can alert a patient and his or her healthcare provider when an infection is about to take hold,” said Linh Le, PhD, founder and CEO of Bonbouton. “This simplifies patient self-monitoring and reduces the frequency of doctor visits, which can ultimately lead to a higher quality of life. I am excited to realize the full potential of Bonbouton, taking a technology that I developed as a graduate student at Stevens and growing it into a product that will bring seamless preventative care to patients and save billions of dollars in healthcare costs.”
Graphene is a monolayer atomic-scale honeycomb lattice of carbon atoms which combines the greatest mechanical strength ever measured in any material (natural or artificial) with very lightweight and high elasticity. Graphene has unique optical and thermal properties which allow it to release energy in the form of heat in response to light input; it also has very high electrical conductivity. The high surface area allows bioconjugation with common biomolecules. Andre Geim and Kostya Novoselov of the University of Manchester (United Kingdom) were awarded the Nobel Prize in Physics in 2010 for its development.
Related Links:
Bonbouton
Stevens Institute of Technology
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







